应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RZLT Rezolute, Inc.
交易中 12-16 14:55:28 EST
2.09
+0.46
+27.91%
最高
2.12
最低
1.63
成交量
1,468万
今开
1.64
昨收
1.63
日振幅
30.37%
总市值
1.93亿
流通市值
1.64亿
总股本
9,273万
成交额
2,619万
换手率
18.62%
流通股本
7,884万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Rezolute高管表示,因严重过敏反应而停药的两名患者未检测到阳性抗药物抗体 - 电话会议
美股速递 · 12-11
Rezolute高管表示,因严重过敏反应而停药的两名患者未检测到阳性抗药物抗体 - 电话会议
Rezolute高管表示,63名参与者中有四名因不良事件早期终止研究
美股速递 · 12-11
Rezolute高管表示,63名参与者中有四名因不良事件早期终止研究
Rezolute股价在盘前暴跌91.3%,原因是罕见疾病药物在晚期研究中未能达到主要目标
美股速递 · 12-11
Rezolute股价在盘前暴跌91.3%,原因是罕见疾病药物在晚期研究中未能达到主要目标
Rezolute, Inc.:肿瘤Hi的第三阶段Uplift研究正在进行中,预计2026年下半年发布初步结果
美股速递 · 12-11
Rezolute, Inc.:肿瘤Hi的第三阶段Uplift研究正在进行中,预计2026年下半年发布初步结果
Rezolute, Inc.盘中异动 临近收盘大幅跳水5.02%报9.65美元
市场透视 · 11-21
Rezolute, Inc.盘中异动 临近收盘大幅跳水5.02%报9.65美元
Rezolute 第一季度每股收益 USD -0.18
投资观察 · 11-20
Rezolute 第一季度每股收益 USD -0.18
Rezolute, Inc.盘中异动 股价大涨5.20%报8.49美元
市场透视 · 10-15
Rezolute, Inc.盘中异动 股价大涨5.20%报8.49美元
Rezolute, Inc.盘中异动 早盘股价大跌5.60%报8.34美元
市场透视 · 10-10
Rezolute, Inc.盘中异动 早盘股价大跌5.60%报8.34美元
Rezolute, Inc.发布2025财年第四季度及全年财务业绩并提供业务进展更新
美股速递 · 09-18
Rezolute, Inc.发布2025财年第四季度及全年财务业绩并提供业务进展更新
Rezolute Inc:FDA确认该公司关键性Sunrize试验正按计划推进,预计2025年12月公布顶线结果
美股速递 · 09-02
Rezolute Inc:FDA确认该公司关键性Sunrize试验正按计划推进,预计2025年12月公布顶线结果
Rezolute, Inc.宣布与FDA就Ersodetug治疗肿瘤性高胰岛素症正在进行的3期试验简化设计达成一致
美股速递 · 09-02
Rezolute, Inc.宣布与FDA就Ersodetug治疗肿瘤性高胰岛素症正在进行的3期试验简化设计达成一致
Rezolute, Inc.盘中异动 股价大涨5.09%
市场透视 · 07-17
Rezolute, Inc.盘中异动 股价大涨5.09%
Rezolute, Inc.盘中异动 股价大涨5.03%
市场透视 · 07-10
Rezolute, Inc.盘中异动 股价大涨5.03%
Rezolute, Inc.盘中异动 急速拉升5.20%
市场透视 · 07-02
Rezolute, Inc.盘中异动 急速拉升5.20%
Rezolute, Inc.盘中异动 快速上涨5.29%报4.58美元
市场透视 · 06-30
Rezolute, Inc.盘中异动 快速上涨5.29%报4.58美元
Rezolute, Inc.盘中异动 股价大涨5.46%
市场透视 · 06-25
Rezolute, Inc.盘中异动 股价大涨5.46%
Rezolute, Inc.盘中异动 快速下挫5.45%
市场透视 · 03-10
Rezolute, Inc.盘中异动 快速下挫5.45%
Rezolute, Inc.盘中异动 下午盘股价大跌5.08%
市场透视 · 03-04
Rezolute, Inc.盘中异动 下午盘股价大跌5.08%
Rezolute, Inc.盘中异动 股价大涨5.42%
市场透视 · 03-01
Rezolute, Inc.盘中异动 股价大涨5.42%
Rezolute, Inc.盘中异动 临近收盘急速下跌5.16%
市场透视 · 02-28
Rezolute, Inc.盘中异动 临近收盘急速下跌5.16%
暂无数据
公司概况
公司名称:
Rezolute, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Rezolute, Inc.于2010年在特拉华州注册成立,并于2021年6月在内华达州重新注册成立。该公司是一家晚期罕见病公司,专注于显著改善由高胰岛素血症(“HI”)引起的低血糖患者的预后。该公司的主要临床资产ersodetug是一种潜在的治疗多种形式的高胰岛素血症引起的低血糖。
发行价格:
--
{"stockData":{"symbol":"RZLT","market":"US","secType":"STK","nameCN":"Rezolute, Inc.","latestPrice":2.085,"timestamp":1765914927876,"preClose":1.63,"halted":0,"volume":14679899,"delay":0,"floatShares":78843300,"shares":92727500,"eps":-0.915073,"marketStatus":"交易中","change":0.455,"latestTime":"12-16 14:55:28 EST","open":1.64,"high":2.12,"low":1.625,"amount":26193627.1077507,"amplitude":0.303681,"askPrice":2.09,"askSize":1000,"bidPrice":2.08,"bidSize":4930,"shortable":0,"etf":0,"ttmEps":-0.915073,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765918800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.63,"preHourTrading":{"tag":"盘前","latestPrice":1.67,"preClose":1.63,"latestTime":"09:29 EST","volume":154676,"amount":254611.2664792,"timestamp":1765895399999},"postHourTrading":{"tag":"盘后","latestPrice":1.6501,"preClose":1.63,"latestTime":"19:59 EST","volume":1077890,"amount":1747653.9402,"timestamp":1765846792367},"volumeRatio":0.479579,"impliedVol":1.3795,"impliedVolPercentile":0.572},"requestUrl":"/m/hq/s/RZLT/tweets","defaultTab":"tweets","newsList":[{"id":"1166602535","title":"Rezolute高管表示,因严重过敏反应而停药的两名患者未检测到阳性抗药物抗体 - 电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1166602535","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166602535?lang=zh_cn&edition=full","pubTime":"2025-12-11 22:11","pubTimestamp":1765462283,"startTime":"0","endTime":"0","summary":"Rezolute高管表示,因严重过敏反应而停药的两名患者未检测到阳性抗药物抗体 - 电话会议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"1136341643","title":"Rezolute高管表示,63名参与者中有四名因不良事件早期终止研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1136341643","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136341643?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:54","pubTimestamp":1765461255,"startTime":"0","endTime":"0","summary":"Rezolute高管表示,63名参与者中有四名患者因不良事件早期终止了研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"1181940294","title":"Rezolute股价在盘前暴跌91.3%,原因是罕见疾病药物在晚期研究中未能达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1181940294","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181940294?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:47","pubTimestamp":1765457249,"startTime":"0","endTime":"0","summary":"Rezolute股价在盘前暴跌91.3%,原因是罕见疾病药物在晚期研究中未能达到主要目标","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"1188653278","title":"Rezolute, Inc.:肿瘤Hi的第三阶段Uplift研究正在进行中,预计2026年下半年发布初步结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1188653278","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188653278?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:02","pubTimestamp":1765454576,"startTime":"0","endTime":"0","summary":"Rezolute, Inc.:肿瘤Hi的第三阶段Uplift研究正在进行中,预计2026年下半年发布初步结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2585660165","title":"Rezolute, Inc.盘中异动 临近收盘大幅跳水5.02%报9.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585660165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585660165?lang=zh_cn&edition=full","pubTime":"2025-11-21 04:55","pubTimestamp":1763672150,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日04时55分,Rezolute, Inc.股票出现异动,股价快速下挫5.02%。截至发稿,该股报9.65美元/股,成交量81.8487万股,换手率0.88%,振幅9.60%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。Rezolute, Inc.公司简介:Rezolute Inc是一家临床阶段的生物制药公司,专注于开发罕见和代谢性疾病的疗法。Rezolute的管线包括旨在改善患者预后并减轻治疗负担的候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121045551977630c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121045551977630c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"1108788621","title":"Rezolute 第一季度每股收益 USD -0.18","url":"https://stock-news.laohu8.com/highlight/detail?id=1108788621","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108788621?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:02","pubTimestamp":1763571779,"startTime":"0","endTime":"0","summary":"11月06日 - Rezolute 第一季度运营费用为1981.7万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2575783147","title":"Rezolute, Inc.盘中异动 股价大涨5.20%报8.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575783147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575783147?lang=zh_cn&edition=full","pubTime":"2025-10-15 02:55","pubTimestamp":1760468133,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日02时55分,Rezolute, Inc.股票出现异动,股价大幅拉升5.20%。截至发稿,该股报8.49美元/股,成交量55.8132万股,换手率0.61%,振幅7.93%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为0.82%。Rezolute, Inc.公司简介:Rezolute Inc是一家临床阶段的生物制药公司,专注于开发罕见和代谢性疾病的疗法。Rezolute的管线包括旨在改善患者预后并减轻治疗负担的候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015025533a4600a33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015025533a4600a33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2574381504","title":"Rezolute, Inc.盘中异动 早盘股价大跌5.60%报8.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574381504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574381504?lang=zh_cn&edition=full","pubTime":"2025-10-10 23:25","pubTimestamp":1760109929,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日23时25分,Rezolute, Inc.股票出现异动,股价急速跳水5.60%。截至发稿,该股报8.34美元/股,成交量37.2752万股,换手率0.41%,振幅5.25%。Rezolute, Inc.股票所在的生物技术行业中,整体跌幅为0.75%。Rezolute, Inc.公司简介:Rezolute Inc是一家临床阶段的生物制药公司,专注于开发罕见和代谢性疾病的疗法。Rezolute的管线包括旨在改善患者预后并减轻治疗负担的候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251010232529a4599c7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251010232529a4599c7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"1100941491","title":"Rezolute, Inc.发布2025财年第四季度及全年财务业绩并提供业务进展更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1100941491","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100941491?lang=zh_cn&edition=full","pubTime":"2025-09-18 04:06","pubTimestamp":1758139572,"startTime":"0","endTime":"0","summary":"Rezolute, Inc.发布2025财年第四季度及全年财务业绩并提供业务进展更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"1148438492","title":"Rezolute Inc:FDA确认该公司关键性Sunrize试验正按计划推进,预计2025年12月公布顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1148438492","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148438492?lang=zh_cn&edition=full","pubTime":"2025-09-02 18:17","pubTimestamp":1756808256,"startTime":"0","endTime":"0","summary":"Rezolute Inc获得FDA确认,其针对先天性疾病的关键性Sunrize试验正按计划推进,预计将于2025年12月公布顶线结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"1111028649","title":"Rezolute, Inc.宣布与FDA就Ersodetug治疗肿瘤性高胰岛素症正在进行的3期试验简化设计达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1111028649","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111028649?lang=zh_cn&edition=full","pubTime":"2025-09-02 18:14","pubTimestamp":1756808057,"startTime":"0","endTime":"0","summary":"Rezolute, Inc.宣布与FDA就Ersodetug治疗肿瘤性高胰岛素症正在进行的3期试验简化设计达成一致","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2552120052","title":"Rezolute, Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552120052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552120052?lang=zh_cn&edition=full","pubTime":"2025-07-17 03:32","pubTimestamp":1752694322,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日03时32分,Rezolute, Inc.股票出现异动,股价急速拉升5.09%。截至发稿,该股报5.37美元/股,成交量44.3648万股,换手率0.51%,振幅5.09%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为1.34%。其相关个股中,知临集团、Geovax Labs Inc C/Wts 29/09/2025、Generation Bio Co.涨幅较大,Qualigen Therapeutics, Inc.、知临集团、Tnf Pharmaceuticals, Inc.较为活跃,换手率分别为2888.20%、2628.88%、1171.61%,振幅较大的相关个股有知临集团、Barinthus Biotherapeutics Plc、Briacell Therapeutics Corp C/Wts 26/02/2026,振幅分别为334.61%、188.24%、77.54%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071703320295452f3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071703320295452f3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2550652171","title":"Rezolute, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550652171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550652171?lang=zh_cn&edition=full","pubTime":"2025-07-10 00:51","pubTimestamp":1752079898,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日00时51分,Rezolute, Inc.股票出现异动,股价快速拉升5.03%。截至发稿,该股报5.22美元/股,成交量51.75万股,换手率0.60%,振幅4.23%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为0.98%。其相关个股中,Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃,换手率分别为1662.18%、746.34%、626.32%,振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Nucana Plc,振幅分别为253.73%、154.98%、130.04%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710005138a69fcff1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710005138a69fcff1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2548815766","title":"Rezolute, Inc.盘中异动 急速拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548815766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548815766?lang=zh_cn&edition=full","pubTime":"2025-07-02 22:19","pubTimestamp":1751465983,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日22时19分,Rezolute, Inc.股票出现波动,股价快速上涨5.20%。截至发稿,该股报4.65美元/股,成交量8.4191万股,换手率0.10%,振幅5.68%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为0.56%。其相关个股中,Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Nutriband Inc C/Wts 涨幅较大,Windtree Therapeutics, Inc.、Lixte Biotechnology Holdings, Inc.、Aditxt, Inc.较为活跃,换手率分别为1813.69%、530.42%、129.38%,振幅较大的相关个股有Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Lixte Biotechnology Holdings, Inc.,振幅分别为1145.92%、393.59%、96.61%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070222194395340959&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070222194395340959&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2547016815","title":"Rezolute, Inc.盘中异动 快速上涨5.29%报4.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547016815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547016815?lang=zh_cn&edition=full","pubTime":"2025-06-30 23:44","pubTimestamp":1751298244,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日23时44分,Rezolute, Inc.股票出现异动,股价快速拉升5.29%。截至发稿,该股报4.58美元/股,成交量47.4267万股,换手率0.55%,振幅7.01%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为0.45%。其相关个股中,Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Vor Biopharma Inc.涨幅较大,Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃,换手率分别为4243.59%、319.61%、106.73%,振幅较大的相关个股有Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ,振幅分别为164.65%、56.94%、50.00%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063023440495316dcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063023440495316dcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2546232888","title":"Rezolute, Inc.盘中异动 股价大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546232888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546232888?lang=zh_cn&edition=full","pubTime":"2025-06-25 00:41","pubTimestamp":1750783305,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日00时41分,Rezolute, Inc.股票出现异动,股价急速上涨5.46%。截至发稿,该股报4.25美元/股,成交量21.1534万股,换手率0.24%,振幅3.85%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为1.86%。其相关个股中,内克塔治疗、Apollomics Inc C/Wts 01/04/2028 、Eyenovia, Inc.涨幅较大,Eyenovia, Inc.、Nucana Plc、Adial Pharmaceuticals, Inc较为活跃,换手率分别为1003.42%、936.04%、533.99%,振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Immatics N V C/Wts 01/07/2025 、Eyenovia, Inc.,振幅分别为188.47%、156.58%、93.98%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625004145a4bbd428&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625004145a4bbd428&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2518628274","title":"Rezolute, Inc.盘中异动 快速下挫5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518628274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518628274?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:57","pubTimestamp":1741615067,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时57分,Rezolute, Inc.股票出现波动,股价急速下挫5.45%。截至发稿,该股报3.64美元/股,成交量3.7545万股,换手率0.06%,振幅3.38%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为2983.67%、650.72%、233.81%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.,振幅分别为41.36%、40.24%、28.59%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021574798a2a3dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021574798a2a3dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2516366838","title":"Rezolute, Inc.盘中异动 下午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516366838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516366838?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:48","pubTimestamp":1741031325,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时48分,Rezolute, Inc.股票出现波动,股价大幅跳水5.08%。截至发稿,该股报4.21美元/股,成交量22.0311万股,换手率0.36%,振幅5.53%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为0.70%。其相关个股中,Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃,换手率分别为4563.20%、208.83%、182.02%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.,振幅分别为206.20%、119.50%、70.53%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304034845a25d97c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304034845a25d97c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2516372678","title":"Rezolute, Inc.盘中异动 股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516372678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516372678?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:13","pubTimestamp":1740762828,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日01时13分,Rezolute, Inc.股票出现异动,股价急速拉升5.42%。截至发稿,该股报4.47美元/股,成交量9.8222万股,换手率0.16%,振幅6.13%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为0.57%。其相关个股中,Bioxcel Therapeutics, Inc.、Camp4 Therapeutics Corporation、Enveric Biosciences, Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为3080.88%、502.73%、371.83%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ,振幅分别为57.80%、49.50%、48.19%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301011349a258291f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301011349a258291f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2514337363","title":"Rezolute, Inc.盘中异动 临近收盘急速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514337363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514337363?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:43","pubTimestamp":1740689007,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时43分,Rezolute, Inc.股票出现波动,股价大幅下跌5.16%。截至发稿,该股报4.23美元/股,成交量23.3931万股,换手率0.39%,振幅6.37%。Rezolute, Inc.股票所在的生物技术行业中,整体跌幅为0.48%。其相关个股中,Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃,换手率分别为1943.10%、410.31%、197.19%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation,振幅分别为86.14%、67.32%、55.84%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044328989553ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044328989553ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rezolutebio.com","stockEarnings":[{"period":"1week","weight":-0.8397},{"period":"1month","weight":-0.8349},{"period":"3month","weight":-0.7889},{"period":"6month","weight":-0.5995},{"period":"1year","weight":-0.6449},{"period":"ytd","weight":-0.6673}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rezolute, Inc.于2010年在特拉华州注册成立,并于2021年6月在内华达州重新注册成立。该公司是一家晚期罕见病公司,专注于显著改善由高胰岛素血症(“HI”)引起的低血糖患者的预后。该公司的主要临床资产ersodetug是一种潜在的治疗多种形式的高胰岛素血症引起的低血糖。","yearOnYearQuotes":[{"month":1,"riseRate":0.857143,"avgChangeRate":0.368938},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.06955},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.097773},{"month":4,"riseRate":0.714286,"avgChangeRate":0.066618},{"month":5,"riseRate":0.5,"avgChangeRate":0.053517},{"month":6,"riseRate":0.75,"avgChangeRate":0.163559},{"month":7,"riseRate":0.5,"avgChangeRate":0.338882},{"month":8,"riseRate":0.5,"avgChangeRate":-0.011128},{"month":9,"riseRate":0.375,"avgChangeRate":-0.025618},{"month":10,"riseRate":0.25,"avgChangeRate":-0.158563},{"month":11,"riseRate":0.25,"avgChangeRate":0.027082},{"month":12,"riseRate":0.25,"avgChangeRate":-0.209289}],"exchange":"NASDAQ","name":"Rezolute, Inc.","nameEN":"Rezolute, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rezolute, Inc.(RZLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rezolute, Inc.(RZLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rezolute, Inc.,RZLT,Rezolute, Inc.股票,Rezolute, Inc.股票老虎,Rezolute, Inc.股票老虎国际,Rezolute, Inc.行情,Rezolute, Inc.股票行情,Rezolute, Inc.股价,Rezolute, Inc.股市,Rezolute, Inc.股票价格,Rezolute, Inc.股票交易,Rezolute, Inc.股票购买,Rezolute, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rezolute, Inc.(RZLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rezolute, Inc.(RZLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}